RxDoctor Payments Data

Jennifer Shaver

Family · Dayton, TNNPI 1245495837

Payments from drug & device makers

$3,207in general payments, 2019–2025

Across 173 payments — averaging $18.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$945
  • AbbVie$426
  • Lilly USA, LLC$324
  • Otsuka America Pharmaceutical, Inc.$308
  • Lundbeck LLC$188
  • Xeris Pharmaceuticals, Inc.$112
  • plus $905 from 19 others

What the payments were for

  • Food & beverage$3,207100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,207 in reported general payments places this provider in the 85th percentile of 6,706 family providers in Tennessee.

See all family providers in Tennessee

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide189$215,266
OzempicSemaglutide93$115,029
EliquisApixaban72$86,830
TrulicityDulaglutide58$70,413
JardianceEmpagliflozin28$39,979
RybelsusSemaglutide24$26,710
VraylarCariprazine Hcl13$22,445
XareltoRivaroxaban23$22,194
FarxigaDapagliflozin Propanediol13$20,805
JanuviaSitagliptin Phosphate32$17,832
RexultiBrexpiprazole12$17,087
LinzessLinaclotide13$16,618
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog20$14,950
Dexlansoprazole DrDexlansoprazole68$14,878
Breo ElliptaFluticasone/Vilanterol15$6,923

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$324$285,678247 claims
Novo NordiskOzempic, Rybelsus$945$141,740117 claims
PfizerEliquis, Premarin$87$90,25583 claims
AbbVieVraylar, Linzess$426$39,06226 claims
Johnson & JohnsonXarelto$15$22,19423 claims
Otsuka America Pharmaceutical, Inc.Rexulti$308$17,08712 claims
GSKBreo Ellipta$109$6,92315 claims
Sanofi-aventis U.S. LLCLantus$24$2,92724 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 6,706 family providers in Tennessee.

Other family in Dayton

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →